Literature DB >> 1368067

High expression vectors for the production of recombinant single-chain urinary plasminogen activator from Escherichia coli.

R Brigelius-Flohé1, G Steffens, W Strassburger, L Flohé.   

Abstract

An expression cassette containing a synonymous gene for human single-chain urokinase-type plasminogen activator (Rscu-PA) 5'-flanked by a trp promoter and the Shine-Dalgarno sequence of the xyl A operon of Bacillus subtilis and terminated by the terminators trp A and Tn10 was constructed and inserted into a pBR322 derivative to yield pBF160. When compared to pUK54 trp 207-1 containing the natural scu-PA gene without the Shine-Dalgarno sequence and terminator, the expression efficiency of pBF160 in Escherichia coli strains was improved by one order of magnitude. Replacement of the trp by the tac promoter (pBF171) did not affect expression. Inserting the Shine-Dalgarno sequence and Tn10 terminator into pUK54 trp 207-1 (pWH1320) slightly increased the expression level, whereas elimination of the Shine-Dalgarno sequence and the terminators from pBF160 with almost complete conservation of the synonymous structural gene (pBF191) significantly reduced the expression. Variation of the distance between the Shine-Dalgarno sequence and the start codon between 8 and 10 bp (pBF163) proved irrelevant. In conclusion, poor expression of mammalian genes in E. coli may result from both improperly designed regulatory elements and structural features of the coding region and therefore de-novo synthesis of the gene may be required to obtain satisfactory expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1368067     DOI: 10.1007/bf00183242

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  22 in total

1.  Predicting optimal and suboptimal secondary structure for RNA.

Authors:  J A Jaeger; D H Turner; M Zuker
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

2.  Stability of the pBR322 plasmid as affected by the promoter region of the tetracycline-resistance gene.

Authors:  M N Kolot; M V Kashlev; A I Gragerov; I A Khmel
Journal:  Gene       Date:  1989-02-20       Impact factor: 3.688

3.  Codon usage tabulated from the GenBank genetic sequence data.

Authors:  T Maruyama; T Gojobori; S Aota; T Ikemura
Journal:  Nucleic Acids Res       Date:  1986       Impact factor: 16.971

4.  Increased plasminogen activator (urokinase) in tissue culture after fibrin deposition.

Authors:  M B Bernik
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

5.  Carbohydrate composition and presence of a fucose-protein linkage in recombinant human pro-urokinase.

Authors:  E J Kentzer; A Buko; G Menon; V K Sarin
Journal:  Biochem Biophys Res Commun       Date:  1990-08-31       Impact factor: 3.575

6.  The primary structure of high molecular mass urokinase from human urine. The complete amino acid sequence of the A chain.

Authors:  W A Günzler; G J Steffens; F Otting; S M Kim; E Frankus; L Flohé
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1982-10

7.  Randomised double-blind trial of recombinant pro-urokinase against streptokinase in acute myocardial infarction. PRIMI Trial Study Group.

Authors: 
Journal:  Lancet       Date:  1989-04-22       Impact factor: 79.321

8.  The AGG codon is translated slowly in E. coli even at very low expression levels.

Authors:  F Bonekamp; K F Jensen
Journal:  Nucleic Acids Res       Date:  1988-04-11       Impact factor: 16.971

9.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

10.  Construction and characterization of new cloning vehicles. V. Mobilization and coding properties of pBR322 and several deletion derivatives including pBR327 and pBR328.

Authors:  L Covarrubias; L Cervantes; A Covarrubias; X Soberón; I Vichido; A Blanco; Y M Kupersztoch-Portnoy; F Bolivar
Journal:  Gene       Date:  1981 Jan-Feb       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.